Latest Breaking News On - Chief Medical Officer Marc Salzbe: AMP

DSMC finds no safety concerns, allows use of highest dose for continued administration. Interim analysis of the trial expected in next month Company opens Spanish subsidiary to lead

Meghan rileyMarc salzbergAirway therapeuticsEuropean medicines agencyAirway spainAirway therapeutics incData safety monitoring committeeChief medical officer marc salzberg

Airway Therapeutics Completes Dose Escalation in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia

Airway Therapeutics Completes Dose Escalation in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Marc salzbergMeghan rileyAirway spainAirway therapeuticsEuropean medicines agencyData safety monitoring committeeAirway therapeutics incWall streetChief medical officer marc salzberg

Latest Breaking News On - Chief medical officer marc salzberg - Page 1 : comparemela.com

Airway Therapeutics, Inc : Airway Therapeutics Completes Dose Escalation in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia

Airway Therapeutics Completes Dose Escalation in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia